Not every patient benefits equally from adaptive therapy, and some may not benefit at all. How do we tell them apart? @stroblmar.bsky.social created this graphic to show how our biomarkers can answer this question!
Schmidt Science Fellow @ Massachusetts General Hospital | Harvard Medical School | Broad Institute (Vazquez-Garcia lab). Developing quantitative tools to study cancer evolution through longitudinal and single cell genomics.